These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1675134)

  • 1. Beta 2 agonists and asthma.
    Rees J
    BMJ; 1991 May; 302(6786):1166-7. PubMed ID: 1675134
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of long-acting beta-agonists--an urgent need to clear the air.
    Martinez FD
    N Engl J Med; 2005 Dec; 353(25):2637-9. PubMed ID: 16371628
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-acting beta agonists in asthma therapy.
    Rissmiller RW; Larj MJ; Peters SP
    Curr Allergy Asthma Rep; 2004 Mar; 4(2):91-2. PubMed ID: 14769255
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of beta(2)-agonists in children.
    Kabesch M
    J Allergy Clin Immunol; 2009 Dec; 124(6):1195-6. PubMed ID: 19910024
    [No Abstract]   [Full Text] [Related]  

  • 6. Are there any detrimental effects of the use of inhaled long-acting beta 2-agonists in the treatment of asthma?
    Devoy MA; Fuller RW; Palmer JB
    Chest; 1995 Apr; 107(4):1116-24. PubMed ID: 7705125
    [No Abstract]   [Full Text] [Related]  

  • 7. Bronchodilating effect of formoterol but not of salmeterol in two asthmatic patients.
    Noppen M; Vincken W
    Respiration; 2000; 67(1):112-3. PubMed ID: 10705276
    [No Abstract]   [Full Text] [Related]  

  • 8. The challenge of long-acting beta-adrenoceptor agonists.
    Rabe KF; Chung KF
    Respir Med; 1991 Jan; 85(1):5-9. PubMed ID: 1673034
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-acting beta(2)-agonists in childhood asthma: Don't change a winning team (yet).
    Verberne AA; de Jongste JC
    Pediatr Pulmonol; 2000 Mar; 29(3):169-71. PubMed ID: 10686035
    [No Abstract]   [Full Text] [Related]  

  • 10. Long acting beta 2 agonists and the risk of life threatening asthma.
    Ernst P
    Thorax; 1998 Jan; 53(1):1-2. PubMed ID: 9577513
    [No Abstract]   [Full Text] [Related]  

  • 11. Is there a need for another inhalative beta(2)-agonist besides formoterol in patients with asthma?
    Matthys H
    Respiration; 2001; 68(4):432-7. PubMed ID: 11464097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta2-agonists--from pharmacological properties to everyday clinical practice.
    Pauwels R
    Respir Med; 2001 Aug; 95 Suppl B():S1. PubMed ID: 11534889
    [No Abstract]   [Full Text] [Related]  

  • 13. Asthma exacerbations and formoterol.
    Rissmiller RW; Larj MJ; Peters SP; Bleecker ER
    Chest; 2004 Apr; 125(4):1590-1. PubMed ID: 15078782
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-acting beta-agonists, tachyphylaxis, and corticosteroids.
    Sears MR
    Chest; 1996 Apr; 109(4):862-4. PubMed ID: 8635359
    [No Abstract]   [Full Text] [Related]  

  • 15. New pharmacologic agents in the treatment of asthma.
    Blaiss MS
    Allergy Proc; 1993; 14(1):17-21. PubMed ID: 8096486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of bronchoprotection with salmeterol.
    D'Urzo AD
    Chest; 1996 Jul; 110(1):306. PubMed ID: 8681659
    [No Abstract]   [Full Text] [Related]  

  • 17. Why SMART about second-line treatment when first-line treatment is being ignored?
    Currie GP
    Chest; 2006 Sep; 130(3):929; author reply 929. PubMed ID: 16963701
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of long-acting beta-agonists: urgent need to clear the air remains.
    Beasley R; Martinez FD; Hackshaw A; Rabe KF; Sterk PJ; Djukanovic R
    Eur Respir J; 2009 Jan; 33(1):3-5. PubMed ID: 19118222
    [No Abstract]   [Full Text] [Related]  

  • 19. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007695. PubMed ID: 19821436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled long acting beta agonists for stable chronic asthma.
    Walters EH; Walters JA; Gibson MD
    Cochrane Database Syst Rev; 2003; (4):CD001385. PubMed ID: 14583933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.